Individual vial: Retatrutide 5mg (vial only)
A quality compounding pharmacy should perform potency testing on each batch, sterility testing using validated methods, endotoxin testing (LAL assay) on injectable products, and beyond-use dating studies to verify how long their products remain effective
Exposure to a challenging environment in the womb increases the risk of future diabetes, obesity and heart disease
Michael Chichak, MD, medical director of MEDvidi, agrees
Peptides P1P3 showed potency on both GCGR and GLP-1R, and P4 and P5 have an EC50 of 68pM or better at both receptors
[4] [5] Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain, particularly during the initial titration phase